Brief: Relay Therapeutics Q1 Net Income USD -73.291 Million Vs. IBES Estimate USD -65 Million
05/05/2026 21:05
May 05 (Reuters) - Relay Therapeutics Q1 basic EPS USD -0.41. Q1 operating income USD -78.59 million Q1 operating expenses USD 81.59 million Q1 revenue USD 3 million vs. IBES estimate USD 2.56 million Q1 EPS USD -0.41
Recent news on Relay Therapeutics
See all newsBrief: X-Chem Announces Phase 3 Milestone In Collaboration With Relay Therapeutics
Relay Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Relay Therapeutics Q2 revenue misses estimates on higher R&D expenses; net loss widens
Brief: Relay Therapeutics Q2 Net Income USD -83.707 Million Vs. IBES Estimate USD -74.2 Million
U.S. RESEARCH ROUNDUP- Alliant Energy, Prog Holdings, Travelers